Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT (HCPCS S3399) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 27, 2026 , from http://ppman.hank.ai/transparency/procedure/S3399/by-state?code_type=HCPCS
“ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT (HCPCS S3399) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/S3399/by-state?code_type=HCPCS. Accessed
June 27, 2026 .
“ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT (HCPCS S3399) by State,” HANK Price Transparency ,
accessed June 27, 2026 ,
http://ppman.hank.ai/transparency/procedure/S3399/by-state?code_type=HCPCS.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
HCPCS · across United States
S3399 — Onasemnogene Abeparvovec-xioi 2 X 10exp13 Vg/ml IV Suspension,kit
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$3,669,056
National median
$2,987,097 – $4,475,009
IQR (p25 – p75)
13
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for S3399 (HCPCS), with interquartile range
State Median p25 p75
OH $3,669,056 $2,987,097 $4,475,009